{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:58:02Z","timestamp":1785545882423,"version":"3.56.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Invasive pulmonary aspergillosis has been increasingly reported in nonneutropenic patients, including those with underlying respiratory diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We compared the diagnostic performances of galactomannan, 1,3-\u03b2-D-glucan, and Aspergillus-specific lateral-flow device tests with that of conventional culture by using bronchoalveolar lavage fluid samples from patients with underlying respiratory diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed 268 bronchoalveolar lavage samples from 221 patients with underlying respiratory diseases (and without hematologic malignancy or previous solid organ transplantation) that were collected for routine microbiological workup between February 2012 and May 2014 at the University Hospital of Graz, Austria. Invasive pulmonary aspergillosis was defined according to European Organization of Research and Treatment of Cancer\/Mycoses Study Group criteria modified for patients with respiratory diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Thirty-one patients (14%) had probable or proven, 25 possible, and the remaining 165 patients no invasive pulmonary aspergillosis. Probable\/proven aspergillosis was associated with a significantly higher (P = 0.034) 30-day mortality rate of 32%. Sensitivities, specificities, and diagnostic odd ratios differed markedly between galactomannan (cut-off 0.5: optical density index, 0.97, 0.81, 124.4; cut-off 1.0: 0.97, 0.93, 422.1; cut-off 3.0: 0.61, 0.99, 109.8), \u03b2-D-glucan (cut-off 80 pg\/ml: 0.90, 0.42, 6.57; cut-off 200 pg\/ml: 0.70, 0.61, 3.7), lateral-flow device tests (0.77, 0.92, 41.8), and mycological culture (0.29, 0.97, 14).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Probable or proven invasive pulmonary aspergillosis was diagnosed in 14% of our study population and associated with significantly higher 30-day mortality rates. Although the performance of \u03b2-D-glucan was limited by low specificity and that of mycological culture by low sensitivity, the Aspergillus lateral-flow device seems to be a promising alternative to galactomannan testing, which remains the diagnostic gold standard for aspergillosis.<\/jats:p>\n                    <jats:p>Clinical trial registered with www.clinicaltrials.gov (NCT 02058316).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201407-1275oc","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T12:49:45Z","timestamp":1413377385000},"page":"922-929","source":"Crossref","is-referenced-by-count":119,"title":["Novel Tests for Diagnosis of Invasive Aspergillosis in Patients with Underlying Respiratory Diseases"],"prefix":"10.1093","volume":"190","author":[{"given":"Juergen","family":"Prattes","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases and Tropical Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Flick","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Pr\u00fcller","sequence":"additional","affiliation":[{"name":"Clinical Institute of Medical and Chemical Laboratory Diagnostics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Koidl","sequence":"additional","affiliation":[{"name":"Institute of Hygiene, Microbiology, and Environmental Medicine, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard B.","family":"Raggam","sequence":"additional","affiliation":[{"name":"Clinical Institute of Medical and Chemical Laboratory Diagnostics, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Palfner","sequence":"additional","affiliation":[{"name":"Division of Pulmonology, Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Eigl","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Tropical Medicine and"},{"name":"Division of Pulmonology, Department of Internal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Buzina","sequence":"additional","affiliation":[{"name":"Institute of Hygiene, Microbiology, and Environmental Medicine, Medical University of Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Zollner-Schwetz","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Tropical Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Thornton","sequence":"additional","affiliation":[{"name":"Biosciences, University of Exeter, Exeter, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Krause","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Tropical Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hoenigl","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Tropical Medicine and"},{"name":"Division of Pulmonology, Department of Internal Medicine"},{"name":"Division of Infectious Diseases, University of California, San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"2026032100300153200_bib1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/13693786.2011.603102","article-title":"Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies","volume":"50","author":"Hoenigl","year":"2012","journal-title":"Med Mycol"},{"key":"2026032100300153200_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1439-0507.2010.01881.x","article-title":"Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies","volume":"54","author":"Hoenigl","year":"2011","journal-title":"Mycoses"},{"key":"2026032100300153200_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ijantimicag.2010.08.010","article-title":"The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and\/or immunosuppressed patients","volume":"36","author":"Perkhofer","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"2026032100300153200_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2026032100300153200_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jinf.2014.03.018","article-title":"Unusual forms of subacute invasive pulmonary aspergillosis in patients with solid tumors","volume":"69","author":"Peghin","year":"2014","journal-title":"J Infect"},{"key":"2026032100300153200_bib6","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1002\/cncr.24559","article-title":"Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases","volume":"115","author":"Yan","year":"2009","journal-title":"Cancer"},{"key":"2026032100300153200_bib7","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1469-0691.2009.03015.x","article-title":"Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome","volume":"16","author":"Guinea","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"2026032100300153200_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1479972307085637","article-title":"Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature","volume":"5","author":"Samarakoon","year":"2008","journal-title":"Chron Respir Dis"},{"key":"2026032100300153200_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign","volume":"44","author":"Greene","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026032100300153200_bib10","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1086\/521245","article-title":"The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients","volume":"45","author":"Lass-Fl\u00f6rl","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026032100300153200_bib11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1086\/657065","article-title":"Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2026032100300153200_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1086\/653684","article-title":"Underestimating the real burden of invasive fungal infections in hematopoietic stem cell transplant recipients?","volume":"51","author":"Hoenigl","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2026032100300153200_bib13","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1086\/647935","article-title":"Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases","volume":"49","author":"Maertens","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2026032100300153200_bib14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422009","article-title":"Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance","volume":"190","author":"Marr","year":"2004","journal-title":"J Infect Dis"},{"key":"2026032100300153200_bib15","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/JCM.03500-13","article-title":"Long-term stability at -20 \u00b0C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens","volume":"52","author":"Wheat","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2026032100300153200_bib16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1600-6143.2004.00415.x","article-title":"Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients","volume":"4","author":"Husain","year":"2004","journal-title":"Am J Transplant"},{"key":"2026032100300153200_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1469-0691.2008.02122.x","article-title":"Correlation between galactomannan antigen levels in serum and neutrophil counts in haematological patients with invasive aspergillosis","volume":"15","author":"Cordonnier","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"2026032100300153200_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100300153200_bib19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2011-04-351601","article-title":"The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies","volume":"119","author":"Bergeron","year":"2012","journal-title":"Blood"},{"key":"2026032100300153200_bib20","doi-asserted-by":"crossref","first-page":"e43347","DOI":"10.1371\/journal.pone.0043347","article-title":"Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis","volume":"7","author":"Zou","year":"2012","journal-title":"PLoS ONE"},{"key":"2026032100300153200_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2004.04904.x","article-title":"Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematological stem cell transplant recipients","volume":"125","author":"Buchheidt","year":"2004","journal-title":"Br J Haematol"},{"key":"2026032100300153200_bib22","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1128\/JCM.06423-11","article-title":"Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity","volume":"50","author":"D\u2019Haese","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2026032100300153200_bib23","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2026032100300153200_bib24","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/jac\/dks208","article-title":"Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies","volume":"67","author":"Reinwald","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2026032100300153200_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201403-0431OC","article-title":"Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease","volume":"190","author":"Affolter","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100300153200_bib26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/CVI.00068-08","article-title":"Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis","volume":"15","author":"Thornton","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"2026032100300153200_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jinf.2012.10.003","article-title":"Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients","volume":"65","author":"Hoenigl","year":"2012","journal-title":"J Infect"},{"key":"2026032100300153200_bib28","doi-asserted-by":"crossref","DOI":"10.3791\/3721","article-title":"Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology","author":"Thornton","year":"2012","journal-title":"J Vis Exp"},{"key":"2026032100300153200_bib29","article-title":"Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semiprospective multicenter study","author":"Willinger","journal-title":"Transplantation"},{"key":"2026032100300153200_bib30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/JCM.02142-12","article-title":"Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis","volume":"51","author":"Wiederhold","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2026032100300153200_bib31","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/JCM.00467-14","article-title":"Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis","volume":"52","author":"Hoenigl","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2026032100300153200_bib32","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2026032100300153200_bib33","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"\u03b2-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026032100300153200_bib34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jinf.2014.04.008","article-title":"The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections","volume":"69","author":"Rose","year":"2014","journal-title":"J Infect"},{"key":"2026032100300153200_bib35","first-page":"A2695","article-title":"Bronchoalveolar lavage lateral-flow device test for diagnosing invasive pulmonary aspergillosis in pulmonology and ICU patients [abstract]","volume":"189","author":"Hoenigl","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100300153200_bib36","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/jac\/dks155","article-title":"European Organization for the Research and Treatment of Cancer\/Mycoses Study Group (EORTC\/MSG) host factors and invasive fungal infections in patients with haematological malignancies","volume":"67","author":"Hoenigl","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2026032100300153200_bib37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/mmy\/myu023","article-title":"Automation of serum (1\u21923)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia","volume":"52","author":"Pr\u00fcller","year":"2014","journal-title":"Med Mycol"},{"key":"2026032100300153200_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0256-4947.62828","article-title":"Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests","volume":"30","author":"Gao","year":"2010","journal-title":"Ann Saudi Med"},{"key":"2026032100300153200_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11908-010-0132-1","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease","volume":"12","author":"Ader","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"2026032100300153200_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s001340000768","article-title":"Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care?","volume":"27","author":"Bulpa","year":"2001","journal-title":"Intensive Care Med"},{"key":"2026032100300153200_bib41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100300153200_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jhin.2004.01.006","article-title":"Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence","volume":"56","author":"Vandewoude","year":"2004","journal-title":"J Hosp Infect"},{"key":"2026032100300153200_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1164\/rccm.200509-1461OC","article-title":"Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease","volume":"174","author":"Berenson","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100300153200_bib44","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1183\/09031936.00018908","article-title":"Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction","volume":"31","author":"Chung","year":"2008","journal-title":"Eur Respir J"},{"key":"2026032100300153200_bib45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/cncr.23570","article-title":"Bronchogenic carcinoma and secondary aspergillosis\u2014common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis","volume":"113","author":"Shahid","year":"2008","journal-title":"Cancer"},{"key":"2026032100300153200_bib46","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/CCM.0b013e318236f297","article-title":"Systemic antifungal therapy in critically ill patients without invasive fungal infection","volume":"40","author":"Azoulay","year":"2012","journal-title":"Crit Care Med"},{"key":"2026032100300153200_bib47","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1128\/AAC.00167-13","article-title":"cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany","volume":"57","author":"Bader","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2026032100300153200_bib48","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1128\/AAC.00251-13","article-title":"Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies","volume":"57","author":"Hoenigl","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2026032100300153200_bib49","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1007\/s00134-009-1482-8","article-title":"Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study","volume":"35","author":"Meersseman","year":"2009","journal-title":"Intensive Care Med"},{"key":"2026032100300153200_bib50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QCO.0000000000000005","article-title":"Azole resistance in Aspergillus fumigatus: a growing public health concern","volume":"26","author":"Vermeulen","year":"2013","journal-title":"Curr Opin Infect Dis"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/190\/8\/922\/67286089\/ajrccm_190_8_922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/190\/8\/922\/67286089\/ajrccm_190_8_922.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:30:10Z","timestamp":1774067410000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/190\/8\/922\/8505296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,10,1]]},"published-print":{"date-parts":[[2014,10,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201407-1275oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,10]]},"published":{"date-parts":[[2014,10,1]]}}}